Construction of predictive models for recurrence and progression in >1000 patients with non-muscle-invasive bladder cancer (NMIBC) from a single centre.

Construction of predictive models for recurrence and progression in >1000 patients with non-muscle-invasive bladder cancer (NMIBC) from a single centre.

OBJECTIVE: To construct predictive models based on the objectively calculated risks of progression and recurrence of non-muscle-invasive bladder cancer (NMIBC) in a large cohort of patients from a single centre. PATIENTS AND METHODS: Between October 1984 and March 2009 a cohort of 1019 patients (87...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Ali-El-Dein, B, Sooriakumaran, P, Trinh, Q, Barakat, T, Nabeeh, A, Ibrahiem, E
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2013

Παρόμοια τεκμήρια

Early re-resection of high grade non-muscle-invasive urothelial carcinoma of the bladder (NMIBC): a 5 year experience (2007-2011) of safety and quality
ανά: Bryant, R, κ.ά.
Έκδοση: (2012)

Role and rationale of gene therapy and other novel therapies in the management of NMIBC.
ανά: Lojo Rial, C, κ.ά.
Έκδοση: (2009)

Predictive biomarkers in muscle-invasive bladder cancer
ανά: Walker, A
Έκδοση: (2017)

PemBla: a Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancer
ανά: Woodcock, VK, κ.ά.
Έκδοση: (2023)

Utility of bladder-sparing therapy vs radical cystectomy for muscle-invasive bladder cancer
ανά: Efstathiou, J, κ.ά.
Έκδοση: (2018)

Contemporary patterns of multidisciplinary care in patients with muscle-invasive bladder cancer
ανά: Harshman, LC, κ.ά.
Έκδοση: (2017)

Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future
ανά: Hermans, TJN, κ.ά.
Έκδοση: (2017)

THE HYPOXIC REGULATION OF FGFR3 IN NON MUSCLE INVASIVE BLADDER CANCER
ανά: Blick, C, κ.ά.
Έκδοση: (2011)

Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network
ανά: Zuiverloon, TCM, κ.ά.
Έκδοση: (2018)

Predictive factors for time to progression after hyperthermic mitomycin C treatment for high-risk non-muscle invasive urothelial carcinoma of the bladder: an observational cohort study of 97 patients
ανά: Sooriakumaran, P, κ.ά.
Έκδοση: (2016)

The management of non-muscle-invasive bladder cancer: A comparison of European and UK guidelines
ανά: Leiblich, A, κ.ά.
Έκδοση: (2018)

MRE11 variants as predictive markers of radiotherapy response in muscle invasive bladder cancer
ανά: Teo, M, κ.ά.
Έκδοση: (2012)

Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer.
ανά: Choudhury, A, κ.ά.
Έκδοση: (2011)

Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression.
ανά: Crew, J, κ.ά.
Έκδοση: (2000)

Mouse models of muscle-invasive bladder cancer: Key considerations for clinical translation based on molecular subtypes
ανά: Ruan, J, κ.ά.
Έκδοση: (2018)

MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.
ανά: Choudhury, A, κ.ά.
Έκδοση: (2010)

Intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancer: Interventional procedures guidance [IPG628]
ανά: National Institute for Health and Care Excellence, CA, κ.ά.
Έκδοση: (2018)

Electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancer: Interventional procedures guidance [IPG638]
ανά: National Institute for Health and Care Excellence, CA, κ.ά.
Έκδοση: (2019)

Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion.
ανά: Fujiyama, C, κ.ά.
Έκδοση: (2001)

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder
ανά: Blick, C, κ.ά.
Έκδοση: (2012)

A multicentre NCRI phase II study of hypofractionated conformal radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer
ανά: Choudhury, A, κ.ά.
Έκδοση: (2010)

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
ανά: Blick, C, κ.ά.
Έκδοση: (2012)

High-throughput DNA sequencing identifies novel CtIP (RBBP8) variants in muscle-invasive bladder cancer patients
ανά: Jevons, S, κ.ά.
Έκδοση: (2015)

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer
ανά: Teo, M, κ.ά.
Έκδοση: (2014)

Ultrasound mediated gemcitabine delivery reduces the normal tissue toxicity of chemoradiation therapy in a muscle-invasive bladder cancer model
ανά: Ruan, J-L, κ.ά.
Έκδοση: (2021)

Celebration of London Irish Centre's 1000 mile cycle
ανά: London Irish Centre, LIC
Έκδοση: (1983)

Improving gene array analysis: The application of artificial intelligence identifies novel biomarkers of non invasive papillary bladder cancer progression
ανά: Wild, P, κ.ά.
Έκδοση: (2007)

Promoter hypermethylation identifies progression risk in bladder cancer.
ανά: Yates, DR, κ.ά.
Έκδοση: (2007)

High MRE11 expression in muscle invasive bladder cancer is predictive of improved cause-specific survival following radical radiotherapy compared to surgery
ανά: Teo, T, κ.ά.
Έκδοση: (2010)

High levels of patient satisfaction in joint uro-oncology clinics to assist patient choice in early prostate cancer and muscle-invasive bladder cancer
ανά: Kiltie, A, κ.ά.
Έκδοση: (2018)

Papillary and muscle invasive bladder tumors with distinct genomic stability profiles have different DNA repair fidelity and KU DNA-binding activities.
ανά: Bentley, J, κ.ά.
Έκδοση: (2009)

High levels of patient satisfaction in joint uro-oncology clinics to assist patient choice in early prostate cancer and muscle-invasive bladder cancer
ανά: Kiltie, A, κ.ά.
Έκδοση: (2018)

Role of thymidine phosphorylase in an in vitro model of human bladder cancer invasion.
ανά: Jones, A, κ.ά.
Έκδοση: (2002)

Aberrant promoter methylation in pre-malignant and invasive tumours of the urinary bladder
ανά: Yates, D, κ.ά.
Έκδοση: (2005)

Comparison of treatment outcome for radical surgery versus radical radiotherapy for invasive bladder cancer treated in a UK specialist treatment centre
ανά: Kotwal, S, κ.ά.
Έκδοση: (2007)

Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential
ανά: Derré, L, κ.ά.
Έκδοση: (2023)

Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma.
ανά: Ord, J, κ.ά.
Έκδοση: (2005)

Comparative study of intelligent models for the prediction of bladder cancer progression.
ανά: Abbod, M, κ.ά.
Έκδοση: (2006)

An investigation into the prognostic significance of necrosis and hypoxia in high grade and invasive bladder cancer.
ανά: Ord, J, κ.ά.
Έκδοση: (2007)

An investigation into the prognostic significance of necrosis and hypoxia in high grade and invasive bladder cancer
ανά: Ord, J, κ.ά.
Έκδοση: (2007)